➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
McKinsey
Merck
Mallinckrodt
Dow
Boehringer Ingelheim

Last Updated: October 1, 2020

DrugPatentWatch Database Preview

Patent: 5,082,642

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 5,082,642
Title: Method for catalyzing oxidation/reduction reactions of simple molecules
Abstract:This invention relates to a method for catalyzing the reactions wherein Q=C or N; Z=O or S; X=O, S, NH or NR; R=C.sub.1 to C.sub.8 alkyl which may be linear, branched or cyclized, which comprises: contacting at least one polydentate nitrogen-containing chelating agent complexed with a metal atom with the reactants of one of said reactions, wherein said contacting takes place in the presence of a means for oxidizing when reaction (1) is catalyzed and in the presence of a means for reducing when reaction (2) is catalyzed. A particular reaction is the conversion of NO to NO.sub.2 using water and supported porphines, hemes, phthalocyanines, ethioporphrins sirohemes, particularly heme and heme compounds or derivatives such as methemoglobin, myoglobin, or hemin.
Inventor(s): Bickar; David (Baltimore, MD), Bonaventura; Celia (Beaufort, NC), Bonaventura; Joseph (Beaufort, NC)
Assignee: Duke University (Durham, NC)
Application Number:07/607,634
Patent Claims:see list of patent claims

Details for Patent 5,082,642

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Recordati Rare Diseases, Inc. PANHEMATIN hemin POWDER, FOR SOLUTION 101246 1 1983-07-20   Start Trial Duke University (Durham, NC) 2009-01-21 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKesson
Merck
Mallinckrodt
McKinsey
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.